HEALTH & LIFE SCIENCES NEWS
HEALTH & LIFE SCIENCES NEWS
Exploring critical business and legal issues across the healthcare and life sciences industries
HEALTH & LIFE SCIENCES NEWS
Exploring critical business and legal issues across the healthcare and life sciences industries

This Week in 340B: July 27 – August 10, 2026

Posted In 340B

Find the week’s updates on 340B litigation to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B cases to provide you with a quick summary of relevant updates from the prior week in this industry-shaping body of litigation. Get more details on these 340B cases and all other material 340B cases pending in federal and state courts with the 340B Litigation Tracker.

Issues at Stake: Contract Pharmacy; Rebate Model; Other

  • In two cases challenging a South Dakota law, the court granted the South Dakota state government’s motion to dismiss.
  • Three separate drug manufacturers filed complaints against the Illinois Attorney General to challenge an Illinois state law governing contract pharmacy arrangement.
  • 340B covered entity filed a complaint against a drug manufacturer to challenge the manufacturer’s policy of requiring the submission of detailed claims-level data as a condition of continuing to purchase covered outpatient drugs at the 340B ceiling price.
  • In a case brought by a drug manufacturer seeking judgment on its interpretation of the definition of “patient”, the manufacturer filed a memorandum in opposition to the defendant’s motion to dismiss and an opposition to motion to intervene, and the proposed intervenors filed a reply in support of their joint motion to intervene.
  • In four separate cases brought by 340B covered entities against a group of pharmacy benefit managers and their vertically-integrated pharmacies alleging a breach of contract and violation of state laws, the group of pharmacy benefit managers filed motions to dismiss in each case.
  • In a case brought by a 340B covered entity against the federal government to challenge the Exclusion Rule, the court granted the covered entity’s motion for summary judgment.
  • In [four] appealed cases challenging the federal government’s decision not to approve a drug manufacturer’s rebate model, the D.C. Circuit Court affirmed the district court’s opinion denying the manufacturer’s motion for summary judgment and granting the federal government’s cross motion for summary judgment.
  • In a case brought by a drug manufacturer challenging an Oregon state law governing contract pharmacy arrangements, plaintiff filed a combined opposition to defendants’ and intervenor’s motions for summary judgment and reply in support of its own motion for summary judgment.
  • In a case brought by a drug manufacturer challenging a Maine state law governing contract pharmacy arrangements, the U.S. District Court for the District of Maine issued an order granting defendants’ motion to dismiss plaintiff’s complaint.
  • In a case by a covered entity against an insurance company alleging breach of contract, the parties stipulated to dismiss the action with prejudice.
  • In four cases brought by drug manufacturers challenging a Utah state law governing contract pharmacy arrangements, the Utah state government filed a memorandum in support of its motion to dismiss.
  • In two appealed cases brought by drug manufacturers challenging a Tennessee state law governing contract pharmacy arrangements, the plaintiff-appellants filed their reply briefs.
  • In a consolidated case brought by a drug manufacturer and a trade association for drug manufacturers challenging a Hawaii state law governing contract pharmacy arrangements, the plaintiffs filed a reply in support of their motion to compel discovery from a nonparty third party administrator; the court granted in part and denied in part a third-party motion to quash; and the court held in abeyance the plaintiffs’ motion to compel discovery from two nonparties.
  • In three cases brought by drug manufacturers challenging a Missouri state law governing contract pharmacy arrangements, amici filed a brief in support of appellant and rehearing en banc, in a second case plaintiffs and defendants filed a memorandum in opposition to amended motions to dismiss and a reply memorandum in support of defendants’ motion to dismiss, respectively, and, in a third case, defendants, plaintiffs, and amici filed separate briefs in support of motions for summary judgment.

 

Emily Jane Cook
Emily Cook is a practice area leader for McDermott's Healthcare Regulatory & Compliance practice. She is a national authority on the 340B drug pricing program, and also helps clients navigate the full suite of federal and state regulations that are essential to healthcare operations. Learn more about Emily's practice here.


Reuben Bank
Reuben Bank provides regulatory and transactional counseling on all aspects of state and federal healthcare laws impacting hospitals and healthcare systems.Learn more about Reuben's practice here.


Matthew David
Matthew David focuses his practice on transactional and regulatory matters affecting a wide range of clients in the healthcare industry.Learn more about Matthew's practice here.


Abygail Hoey
Abygail Hoey is a member of the Health & Life Sciences Practice Group, where she focuses her practice on healthcare transactions, as well as regulatory and compliance matters. Learn more about Abygail's practice here.


Margaret Houtz
Margaret (Maggie) Houtz is a member of the Healthcare Practice Group, where she works on a range of transactional and regulatory matters affecting the healthcare industry.Learn more about Maggie's practice here.


Jae Hyun Lee
Jae Hyun Lee is a member of the Healthcare Practice Group. He focuses his practice on healthcare mergers and acquisitions as well as regulatory and compliance matters. Read more about Jae's practice here.


Sydney Merritt Martinez
Sydney Merritt Martinez focuses her practice on health law matters. Learn more about Sydney's practice here.


Deepika Raj
Deepika Raj advises a broad range of healthcare industry clients on regulatory, compliance and transactional matters. She offers multifaceted advice on state and federal fraud and abuse statutes, licensure rules, cannabis laws and due diligence matters. Learn more about Deepika's practice here.


Kelsey Reinhardt
Kelsey R. Reinhardt focuses her practice on regulatory and transactional matters affecting a wide range of clients across the healthcare industry. Learn more about Kelsey's practice here.


Nadine Tejadilla
Nadine Tejadilla focuses her practice on transactional and regulatory matters in the health and life sciences industry. While in law school, Nadine served as a legal intern at a national nonprofit civil rights organization.Learn more about Nadine's practice here.

STAY CONNECTED

TOPICS

ARCHIVES

Chambers 2021 Top Ranked
U.S. News Law Firm of the Year 2022 Health Care Law
LEgal 500 EMEA top tier firm 2021
Legal 500 USA top tier firm